ResearcherTongji UniversityActive in the last 2 years
Xiaohua Jiang
Matched on ORCID iD 0000-0001-7001-4676; OpenAlex author ID A5075369555. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 24
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: 2 papers · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper
Papers 6
- Neurturin-induced activation of GFRA2-RET axis potentiates pancreatic cancer glycolysis via phosphorylated hexokinase 2. Co-author DOI 10.1016/j.canlet.2025.217583↗
- HOXA10 promote pancreatic cancer progression via directly activating canonical NF-κB signaling pathway. Co-author DOI 10.1093/carcin/bgac042↗
- The long coding RNA AFAP1-AS1 promotes tumor cell growth and invasion in pancreatic cancer through upregulating the IGF1R oncogene via sequestration of miR-133… Co-author DOI 10.1080/15384101.2018.1496741↗
- The circadian clock gene Bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathway. Co-author DOI 10.1016/j.canlet.2015.12.002↗
- Association of LncRNA HMlincRNA717 with prognosis in pancreatic cancer. Co-author PMID 27338046↗
- Reduced α-dystroglycan expression correlates with shortened patient survival in pancreatic cancer. Co-author DOI 10.1016/j.jss.2009.11.730↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yongkun Wang · 2 shared papers, 2018–2025 · strength 0.32
- Paper Neurturin-induced activation of GFRA2-RET axis potentiates pancreatic cancer glycolysis via phosphorylated hexokinase 2. DOI 10.1016/j.canlet.2025.217583↗
- Paper The long coding RNA AFAP1-AS1 promotes tumor cell growth and invasion in pancreatic cancer through upregulating the IGF… DOI 10.1080/15384101.2018.1496741↗
- Ran Cui · 1 shared paper, 2025 · strength 0.24
- Bo Chen · 1 shared paper, 2025 · strength 0.24
- Yongwei Sun · 1 shared paper, 2022 · strength 0.16
- Minwei Yang · 1 shared paper, 2022 · strength 0.16
- Yongsheng Jiang · 1 shared paper, 2022 · strength 0.16
- Jiao Li · 1 shared paper, 2022 · strength 0.16
- Junfeng Zhang · 1 shared paper, 2022 · strength 0.16
- Yongping Zhou · 1 shared paper, 2018 · strength 0.08
- Bo Chen · 1 shared paper, 2018 · strength 0.08
- Wujun Xiong · 1 shared paper, 2018 · strength 0.08
- Sun Xl · 1 shared paper, 2016 · strength 0.06
- S-X Yan · 1 shared paper, 2016 · strength 0.06
- Weiliang Jiang · 1 shared paper, 2016 · strength 0.05
- Congying Chen · 1 shared paper, 2016 · strength 0.05
- Rong Wan · 1 shared paper, 2016 · strength 0.05
- Guoyong Hu · 1 shared paper, 2016 · strength 0.05
- Xingpeng Wang · 1 shared paper, 2016 · strength 0.05
- Lijuan Yang · 1 shared paper, 2016 · strength 0.05
- Nathalia A. Giese · 1 shared paper, 2011 · strength 0.03
- Simon Rieder · 1 shared paper, 2011 · strength 0.03
- Christoph W. Michalski · 1 shared paper, 2011 · strength 0.03
- Helmut Friess · 1 shared paper, 2011 · strength 0.03
- Jorg H. Kleeff · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.